NEW YORK (GenomeWeb) – A new CRISPR/Cas9 system designed for editing mouse neurons in vivo uses chemically induced guide RNAs (gRNAs) to help control where and when editing happens.
The virally delivered, doxycycline-inducible system will help University of Texas at Dallas researcher Jonathan Ploski study genes associated with learning and memory in the mouse model. Last month, a Ploski-led team published a study describing it in Frontiers in Molecular Neuroscience.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
